Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DRUG RECALLS FOR 2006

This article was originally published in The Gold Sheet

Executive Summary

...include a surge in Class I-rated actions. Altogether, 27 drug products were recalled that were judged to pose a serious health threat, about two-thirds of which were contaminated. Several contamination-related recalls listed by FDA during the year were associated with FDA inspection findings of significant GMP deviations, including a Class I action involving nine injectable products by a pharmacy compounder. Agency concern about inadequate controls to prevent labeling and packaging mixups prompted a national repacker to recall 174 drug products, swelling the total for the year. FDA is stressing the contamination risks of non-sterile products and is working with industry to upgrade microbial testing practices. [A 12-page tabulation of drug recalls listed in FDA "Enforcement Reports" during 2006 is included.]

You may also be interested in...



Contamination, Mix-Ups Drive Up Drug Recall Totals for 2012

Injectables eclipsed oral solids as 2012 generated the fourth-most recalls ever. Contamination played a major role, particularly in generating several massive recalls at compounding pharmacies, while there were also contraceptive packaging snafus, problems in confronting tablet mix-ups and other issues that generated drug recalls last year.

Advantage Dose's GMP Issues Mirrored Earlier Problems Affecting Repackers

Advantage Dose case reflects major repacker recalls of the past

Advantage Dose's GMP Issues Mirrored Earlier Problems Affecting Repackers

Advantage Dose case reflects major repacker recalls of the past

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel